Literature DB >> 22678227

The effect of enhanced depression care on anxiety symptoms in acute coronary syndrome patients: findings from the COPES trial.

Ian M Kronish, William F Chaplin, Nina Rieckmann, Matthew M Burg, Karina W Davidson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678227      PMCID: PMC3640416          DOI: 10.1159/000332439

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  16 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function?

Authors:  D Benninghoven; A Kaduk; U Wiegand; T Specht; S Kunzendorf; G Jantschek
Journal:  Psychother Psychosom       Date:  2006       Impact factor: 17.659

3.  Contribution of depression and anxiety to impaired health-related quality of life following first myocardial infarction.

Authors:  C M Dickens; L McGowan; C Percival; B Tomenson; L Cotter; A Heagerty; F H Creed
Journal:  Br J Psychiatry       Date:  2006-10       Impact factor: 9.319

4.  GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome.

Authors:  Gordon Parker; Matthew Hyett; Dusan Hadzi-Pavlovic; Heather Brotchie; Warren Walsh
Journal:  Psychiatry Res       Date:  2011-06-08       Impact factor: 3.222

5.  Recognition and treatment of depression and anxiety in patients with acute myocardial infarction.

Authors:  Jeff C Huffman; Felicia A Smith; Mark A Blais; Marguerite E Beiser; James L Januzzi; Gregory L Fricchione
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

6.  Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial.

Authors:  Neil Schneiderman; Patrice G Saab; Diane J Catellier; Lynda H Powell; Robert F DeBusk; Redford B Williams; Robert M Carney; James M Raczynski; Marie J Cowan; Lisa F Berkman; Peter G Kaufmann
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

7.  Relation of anxiety and adherence to risk-reducing recommendations following myocardial infarction.

Authors:  Emily A Kuhl; James A Fauerbach; David E Bush; Roy C Ziegelstein
Journal:  Am J Cardiol       Date:  2009-04-16       Impact factor: 2.778

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Treating persistent depressive symptoms in post-ACS patients: the project COPES phase-I randomized controlled trial.

Authors:  Matthew M Burg; Francois Lespérance; Nina Rieckmann; Lynn Clemow; Christine Skotzko; Karina W Davidson
Journal:  Contemp Clin Trials       Date:  2007-09-05       Impact factor: 2.226

10.  Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.

Authors:  Nancy Frasure-Smith; François Lespérance
Journal:  Arch Gen Psychiatry       Date:  2008-01
View more
  3 in total

Review 1.  Drug therapy for symptoms associated with anxiety in adult palliative care patients.

Authors:  Susan Salt; Caroline A Mulvaney; Nancy J Preston
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

Review 2.  Psychological interventions for coronary heart disease.

Authors:  Suzanne H Richards; Lindsey Anderson; Caroline E Jenkinson; Ben Whalley; Karen Rees; Philippa Davies; Paul Bennett; Zulian Liu; Robert West; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-04-28

Review 3.  Psychological and pharmacological interventions for depression in patients with coronary artery disease.

Authors:  Phillip J Tully; Ser Yee Ang; Emily Jl Lee; Eileen Bendig; Natalie Bauereiß; Jürgen Bengel; Harald Baumeister
Journal:  Cochrane Database Syst Rev       Date:  2021-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.